To dream of imminent solutions is only human. But progress will come from controlled expectations.

We aren't very good at discussing trade-offs, but we need to make some during this pandemic.

"The glacial progress our community has made to remedy our historic and present day exclusion, have been chronicled for longer than I have been alive", says Kenneth Gibbs. 

In the media circus surrounding the pandemic, it's the loudest researchers who have been heard the most. Why it is important that we also listen to quieter voices in future, and why the state of scientific knowledge should be communicated with greater candour.

Technology gave us the dream of a cocooned future. Now we're living it.

The publishing contract reads like a classic big deal for journal subscriptions. But then, only a short addendum of 1.5 pages deals with the new Open Access workflow.

Centuries of bias have impeded the advance of human knowledge. As the COVID-19 pandemic makes evident, new threats may emerge suddenly. The world cannot protect itself without the intelligence and skill of half the human race.

Responses to the pandemic in India's slums, Brazil's favelas and Africa's marketplaces show that networks play a crucial part in making cities more resilient. Let's enhance and empower them.

A century ago, children in New York City attended classes during a pandemic. It seemed to work.

We do not have to live in a constant state of fear that our health is being put at-risk. We can restore and strengthen science-based decision-making processes that are protected from political interference. Today, we are releasing our first set of recommendations providing a roadmap for how the fede

Letting the rich pay for science that interests them is a bad idea—even if they aren’t convicted sex offenders.

Kaoru Sakabe is academic publishing’s version of an in-house detective. In 2017, she and editors at the Journal of Biological Chemistry (JBC) conducted a pilot study looking for image manipulation in accepted papers. When 10% of papers came back with a possible issue, the team was shocked.

Switzerland will soon vote on whether to cancel the agreement on the free movement of persons, thus terminating the well-established Bilateral Agreements with the EU. Only by networking fully with its European neighbors and the world in general, can the high standards the Swiss hold for themselves be maintained.

Schools face rising demands for tuition rebates, increased aid and leaves of absence as students ask if college is becoming "glorified Skype."

Generating new knowledge is a relatively straightforward concept compared with the more unknown territory of getting knowledge to those that might need it.

Universities and those who work there must reimagine spaces, behaviour and processes to promote a sense of belonging for everyone.

Leaked letter to Commission shows major pushback against ERC Scientific Council's doubt over open-access initiative

Pandemic policy must include defining and measuring what we mean by mild infection.

Mike Schäfer & Jing Zeng on the particularities of conspiracy theories on COVID-19, how to face them, and what role science communicators play while doing so.

COVID-19 has turned all journalists into health journalists. Epidemiology training can help journalists improve their reporting, and help fight misinformation.

Hong Kong Principles seek to replace 'publish or perish' culture.

Don't worry, a little Bayesian analysis won't hurt you.

Sampling simulated data can reveal common ways in which our cognitive biases mislead us.

Under the pressure of a global health crisis, the argument for open access has sunk in. Is this the catalyst that breaks up the bonds of an old publishing model once and for all?

The COVID pandemic may leave us stuck between a growing consensus that open science is the superior way to drive progress and an inability to invest what may be needed to make it happen.

Scientists need to show us the data. And that's exactly what they're working on.

On the risks of skipping Phase 3 vaccine trials.

The pandemic is sabotaging the careers of researchers from under-represented groups, but institutions can help to staunch the outflow.

The proposed October coronavirus vaccine deadline intersects nicely with President Trump’s need to curb the virus before the presidential election in November.